ARTICLE | Company News

Bioharmony, Boehringer partner to develop antimicrobials

January 18, 2019 12:59 AM UTC

Antimicrobial company Bioharmony Therapeutics Inc. (New York, N.Y.) partnered with Boehringer Ingelheim GmbH (Ingelheim, Germany) to develop bacteriophage lysins to treat systemic multidrug-resistant Acinetobacter infections.

Bioharmony declined to disclose financial terms and details regarding the partners’ responsibilities under the deal...